Tag Archives: patients

Pfizer’s blockbuster-to-be Vyndaqel is too costly for heart patients, study suggests

Pfizer’s tafamidis arrived in the U.S. in 2019 with a vastly discounted list price over rival transthyretin amyloidosis drugs. But its $ 225,000-a-year tag still seems too much for many heart patients. Previous cost-effectiveness analyses and physicians themselves have warned tafamidis is too pricey—the world’s most expensive medication for cardiovascular disease, to be exact. And now,… Read More »

Report Suggests Some “Mildly Symptomatic” Covid-19 Patients Endure Serious Long-Term Effects

Woman with coronavirus, sick at home Getty The existence of Covid-19 and the SARS-CoV-2 virus that causes the disease has been known for less than half a year. And so it stands to reason that the precise pathogenesis hasn’t been fully characterized. What’s also unclear at this point are reasons for the differential impact the… Read More »

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas Print this page 13 April 2020 — AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo… Read More »

U.S. May Get More Ventilators But Run Out Of Medicine For COVID-19 Patients – NPR

Enlarge this image Vizient, a group purchasing organization that negotiates lower prices with drug manufacturers, sent recommendations that the Food and Drug Administration expand access to drugs heavily used with ventilator patients. jamesbenet/Getty Images hide caption toggle caption jamesbenet/Getty Images As hospitals across the country fill with COVID-19 patients, medical personnel are sounding the alarm… Read More »

Patients at risk of drug-induced sudden cardiac death in COVID-19

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it’s still likely 12 to 18 months away. In the meantime, the pandemic, with over 400,000 confirmed cases worldwide already, is driving researchers to find… Read More »